Published • loading... • Updated
Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
Piramal Pharma Solutions’ net promoter score of 55, validated by DNV, reflects its strong focus on customer centricity and surpasses competitor averages in the CDMO industry.
- Piramal Pharma Solutions announced a Net Promoter Score of 55 for FY2025, validated by DNV from Mumbai, India, reinforcing its position as a trusted industry leader.
- Piramal Pharma Solutions' customer‑centric approach underpins its score through structured annual customer and promoter surveys assessing performance.
- Coordinating the effort, the Customer Centricity team maintains NPS data integrity by collaborating across departments during assurance processes, while insights are analyzed into organization‑wide actionable plans presented to the Board of Directors for the annual Sustainability Report.
- By exceeding competitors' average scores, Peter DeYoung, CEO, said `As we move ahead, the insights gleaned from this year's NPS survey will guide our strategic initiatives, enabling us to further enhance client engagement and operational efficiency,` reinforcing PPS's leadership amid many competitor CDMOs' negative averages.
- With a global network spanning North America, Europe and Asia, Piramal Pharma Solutions operates 17 global development and manufacturing facilities serving over 100 countries and offers specialized capabilities including highly potent APIs and biologics development via Yapan Bio Private Limited.
Insights by Ground AI
20 Articles
20 Articles
+19 Reposted by 19 other sources
Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry averages.A third-party provider, DNV, validated the NPS survey and score.This accomplishment reflects the Organization's dedication to stakeholder centricity and operational excellence.
Coverage Details
Total News Sources20
Leaning Left3Leaning Right4Center7Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 21%
C 50%
R 29%
Factuality
To view factuality data please Upgrade to Premium









